These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23676439)

  • 1. Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines.
    Davis H; Lewis A; Behrens A; Tomlinson I
    Gut; 2014 May; 63(5):792-9. PubMed ID: 23676439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fbxw7 hotspot mutations and human colon cancer: mechanistic insights from new mouse models.
    Grim JE
    Gut; 2014 May; 63(5):707-9. PubMed ID: 24000292
    [No Abstract]   [Full Text] [Related]  

  • 3. FBXW7 mutations typically found in human cancers are distinct from null alleles and disrupt lung development.
    Davis H; Lewis A; Spencer-Dene B; Tateossian H; Stamp G; Behrens A; Tomlinson I
    J Pathol; 2011 Jun; 224(2):180-9. PubMed ID: 21503901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDC4/FBXW7 and the 'just enough' model of tumourigenesis.
    Davis H; Tomlinson I
    J Pathol; 2012 Jun; 227(2):131-5. PubMed ID: 22323043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.
    Babaei-Jadidi R; Li N; Saadeddin A; Spencer-Dene B; Jandke A; Muhammad B; Ibrahim EE; Muraleedharan R; Abuzinadah M; Davis H; Lewis A; Watson S; Behrens A; Tomlinson I; Nateri AS
    J Exp Med; 2011 Feb; 208(2):295-312. PubMed ID: 21282377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.
    Sancho R; Jandke A; Davis H; Diefenbacher ME; Tomlinson I; Behrens A
    Gastroenterology; 2010 Sep; 139(3):929-41. PubMed ID: 20638938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.
    Iwatsuki M; Mimori K; Ishii H; Yokobori T; Takatsuno Y; Sato T; Toh H; Onoyama I; Nakayama KI; Baba H; Mori M
    Int J Cancer; 2010 Apr; 126(8):1828-1837. PubMed ID: 19739118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.
    Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI
    Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBXW7 mutation analysis and its correlation with clinicopathological features and prognosis in colorectal cancer patients.
    Chang CC; Lin HH; Lin JK; Lin CC; Lan YT; Wang HS; Yang SH; Chen WS; Lin TC; Jiang JK; Chang SC
    Int J Biol Markers; 2015 Feb; 30(1):e88-95. PubMed ID: 25450649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability.
    Kemp Z; Rowan A; Chambers W; Wortham N; Halford S; Sieber O; Mortensen N; von Herbay A; Gunther T; Ilyas M; Tomlinson I
    Cancer Res; 2005 Dec; 65(24):11361-6. PubMed ID: 16357143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXW7 mutations in melanoma and a new therapeutic paradigm.
    Aydin IT; Melamed RD; Adams SJ; Castillo-Martin M; Demir A; Bryk D; Brunner G; Cordon-Cardo C; Osman I; Rabadan R; Celebi JT
    J Natl Cancer Inst; 2014 Jun; 106(6):dju107. PubMed ID: 24838835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
    Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
    Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fbxw7 Deletion Accelerates Kras
    Zhang Q; Zhang Y; Parsels JD; Lohse I; Lawrence TS; Pasca di Magliano M; Sun Y; Morgan MA
    Neoplasia; 2016 Nov; 18(11):666-673. PubMed ID: 27764699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.
    King B; Trimarchi T; Reavie L; Xu L; Mullenders J; Ntziachristos P; Aranda-Orgilles B; Perez-Garcia A; Shi J; Vakoc C; Sandy P; Shen SS; Ferrando A; Aifantis I
    Cell; 2013 Jun; 153(7):1552-66. PubMed ID: 23791182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
    Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
    Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FBXW7 beta-form is suppressed in human glioma cells.
    Gu Z; Inomata K; Ishizawa K; Horii A
    Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
    Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
    PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of CDC4/FBXW7 in gastric carcinoma.
    Milne AN; Leguit R; Corver WE; Morsink FH; Polak M; de Leng WW; Carvalho R; Offerhaus GJ
    Cell Oncol; 2010; 32(5-6):347-59. PubMed ID: 20448329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors.
    Kitade S; Onoyama I; Kobayashi H; Yagi H; Yoshida S; Kato M; Tsunematsu R; Asanoma K; Sonoda K; Wake N; Hata K; Nakayama KI; Kato K
    Cancer Sci; 2016 Oct; 107(10):1399-1405. PubMed ID: 27486687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
    Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A
    Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.